Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
February-2016 Volume 4 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2016 Volume 4 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point

  • Authors:
    • Bo Zhang
    • Ming Cheng
    • Ming Yang
    • Shuai Han
    • Ying-Hui Zhang
    • Hong-Guang Shi
    • Liang Zhu
    • Xue-Zhi Zhao
  • View Affiliations / Copyright

    Affiliations: Department of Gastroenterology, Changzheng Hospital Affiliated to the Second Military Medical University, Shanghai 200003, P.R. China, Department of Nephrology, Changzheng Hospital Affiliated to the Second Military Medical University and the Kidney Institute of CPLA, Shanghai 200003, P.R. China, Department of Osteology, Changzheng Hospital Affiliated to the Second Military Medical University, Shanghai 200003, P.R. China, Department of Nephrology, No. 401 Hospital of CPLA, Shandong 266000, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 147-152
    |
    Published online on: December 11, 2015
       https://doi.org/10.3892/br.2015.555
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Idiopathic membranous nephropathy (IMN) is one of the most common causes of nephrotic syndrome (NS) in adults. The latest study of the chronic kidney disease‑prognosis consortium showed that a 30% decrease in the estimated glomerular filtration rate (eGFR) within 2 years could cover more patients and showed a better correlation with end‑stage renal disease (ESRD), as compared with serum creatinine (SCr). The aim of the present study was to analyze prognostic factors of ESRD using a 30% decrease in eGFR within 2 years as the end‑point. The medical records of patients who were diagnosed as having IMN by clinical pathology between February 2011 and August 2012 and had been followed up for ≥24 months were analyzed retrospectively. A 30% decrease in eGFR or the occurrence of ESRD were the end‑points. Factors affecting the prognosis were analyzed by the χ2 test and multivariate logistic regression analysis, and the cumulative risk of risk factors was analyzed by Kaplan‑Meier curve. A total of 73 patients with IMN were confirmed by clinical pathology. Blood pressure, tubulointerstitial injury area (TIA), glomerular sclerosis ratio, SCr, blood urea nitrogen, cystatin C, serum albumin and 24‑h urine protein. In total, 28 patients (38.4%) reached the observation end‑point. Multivariate logistic regression analysis showed that only age ≥60 years, serum albumin <25 g/l and TIA >25% were independent risk factors for predicting the occurrence of end‑point events in the two groups (P<0.05), which increased the risk of the occurrence of end‑point events in IMN patients by 3.471‑, 3.195‑ and 6.724‑fold, respectively. Kaplan‑Meier curve showed that the occurrence of end‑point events within 2 years was significantly higher in IMN patients whose age was ≥60 years, serum albumin <25 g/l and TIA >25% (log‑rank P=0.004, P=0.024 and P=0.001). The results of the present study revealed that age ≥60 years, low serum albumin concentrations and severe tubulointerstitial injury are independent risk factors for the occurrence of ESRD in IMN patients.
View Figures

Figure 1

Figure 2

View References

1 

Kerjaschki D and Farquhar MG: The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci USA. 79:5557–5561. 1982. View Article : Google Scholar : PubMed/NCBI

2 

Heymann W, Hackel DB, Harwood S, Wilson SG and Hunter JL: Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med. 100:660–664. 1959. View Article : Google Scholar : PubMed/NCBI

3 

Zhou FD, Zhao MH, Zou WZ, Liu G and Wang H: The changing spectrum of primary glomerular diseases within 15 years, A survey of 3331 patients in a single Chinese centre. Nephrol Dial Transplant. 24:870–876. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Li LS and Liu ZH: Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int. 66:920–923. 2004. View Article : Google Scholar : PubMed/NCBI

5 

Marx BE and Marx M: Prediction in idiopathic membranous nephropathy. Kidney Int. 56:666–673. 1999. View Article : Google Scholar : PubMed/NCBI

6 

Hogan SL, Muller KE, Jennette JC and Falk RJ: A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis. 25:862–875. 1995. View Article : Google Scholar : PubMed/NCBI

7 

Glassock RJ: Diagnosis and natural course of membranous nephropathy. Semin Nephrol. 23:324–332. 2003. View Article : Google Scholar : PubMed/NCBI

8 

Wasserstein AG: Membranous glomerulonephritis. J Am Soc Nephrol. 8:664–674. 1997.PubMed/NCBI

9 

Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, et al: CKD Prognosis Consortium: Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 311:2518–2531. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al: CKD-EPI (chronic kidney disease epidemiology collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med. 150:604–612. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Stokes MB, Valeri AM, Markowitz GS and D'Agati VD: Cellular focal segmental glomerulosclerosis Clinical and pathologic features. Kidney Int. 70:1783–1792. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH, Somers MJ, Trachtman H and Waldman M: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. Am J Kidney Dis. 62:403–441. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Hofstra JM, Fervenza FC and Wetzels JF: Treatment of idiopathic membranous nephropathy. Nat Rev Nephrol. 9:443–458. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Pan X, Xu J, Ren H, Zhang W, Xu Y, Shen P, Li X, Wang W, Chen X, Wu P, et al: Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: A single-center study in China. Contrib Nephrol. 181:22–30. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S and Remuzzi G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med. 329:85–89. 1993. View Article : Google Scholar : PubMed/NCBI

16 

Polanco N, Gutiérrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D and Praga M: Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN): Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment. Nephrol Dial Transplant. 27:231–234. 2012. View Article : Google Scholar : PubMed/NCBI

17 

McQuarrie EP, Stirling CM and Geddes CC: Idiopathic membranous nephropathy and nephrotic syndrome, Outcome in the era of evidence-based therapy. Nephrol Dial Transplant. 27:235–242. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Yoshimoto K, Yokoyama H, Wada T, Furuichi K, Sakai N, Iwata Y, Goshima S and Kida H: Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. Kidney Int. 65:148–153. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, Yokoyama H, Nishi S, Tomino Y, Kurokawa K, et al: Research Group on Progressive Renal Diseases in Japan: Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 65:1400–1407. 2004. View Article : Google Scholar : PubMed/NCBI

20 

Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K and Harada A: Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone. Nephrol Dial Transplant. 24:3082–3088. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Zuo K, Wu Y, Li SJ, Xu F, Zeng CH and Liu ZH: Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population. Clin Nephrol. 79:445–453. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Zent R, Nagai R and Cattran DC: Idiopathic membranous nephropathy in the elderly, A comparative study. Am J Kidney Dis. 29:200–206. 1997. View Article : Google Scholar : PubMed/NCBI

23 

Garg AX, Kiberd BA, Clark WF, Haynes RB and Clase CM: Albuminuria and renal insufficiency prevalence guides population screening, Results from the NHANES III. Kidney Int. 61:2165–2175. 2002. View Article : Google Scholar : PubMed/NCBI

24 

Wehrmann M, Bohle A, Bogenschütz O, Eissele R, Freislederer A, Ohlschlegel C, Schumm G, Batz C and Gärtner HV: Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol. 31:67–76. 1989.PubMed/NCBI

25 

Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B, et al: A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med. 320:8–13. 1989. View Article : Google Scholar : PubMed/NCBI

26 

Troyanov S, Roasio L, Pandes M, Herzenberg AM and Cattran DC: Renal pathology in idiopathic membranous nephropathy, A new perspective. Kidney Int. 69:1641–1648. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Honkanen E, Törnroth T, Grönhagen-Riska C and Sankila R: Long-term survival in idiopathic membranous glomerulonephritis, Can the course be clinically predicted? Clin Nephrol. 41:127–134. 1994.PubMed/NCBI

28 

Ponticelli C, Passerini P, Altieri P, Locatelli F and Pappalettera M: Remissions and relapses in idiopathic membranous nephropathy. Nephrol Dial Transplant. 7(Suppl 1): 85–90. 1992.PubMed/NCBI

29 

Hladunewich MA, Troyanov S, Calafati J and Cattran DC: Metropolitan Toronto Glomerulonephritis: Registry The natural history of the non-nephrotic membranous nephropathy patient. Clin J Am Soc Nephrol. 4:1417–1422. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Polanco N, Gutiérrez E, Covarsí A, Ariza F, Carreño A, Vigil A, Baltar J, Fernández-Fresnedo G, Martín C, Pons S, et al: Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología: Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol. 21:697–704. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Kaneko K, Kimata T, Tsuji S, Shimo T, Takahashi M and Tanaka S: Serum albumin level accurately reflects antioxidant potentials in idiopathic nephrotic syndrome. Clin Exp Nephrol. 16:411–414. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Roche M, Rondeau P, Singh NR, Tarnus E and Bourdon E: The antioxidant properties of serum albumin. FEBS Lett. 582:1783–1787. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Lewis EJ, Hunsicker LG, Bain RP and Rohde RD: The Collaborative Study, Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 329:1456–1462. 1993. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang B, Cheng M, Yang M, Han S, Zhang Y, Shi H, Zhu L and Zhao X: Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point. Biomed Rep 4: 147-152, 2016.
APA
Zhang, B., Cheng, M., Yang, M., Han, S., Zhang, Y., Shi, H. ... Zhao, X. (2016). Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point. Biomedical Reports, 4, 147-152. https://doi.org/10.3892/br.2015.555
MLA
Zhang, B., Cheng, M., Yang, M., Han, S., Zhang, Y., Shi, H., Zhu, L., Zhao, X."Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point". Biomedical Reports 4.2 (2016): 147-152.
Chicago
Zhang, B., Cheng, M., Yang, M., Han, S., Zhang, Y., Shi, H., Zhu, L., Zhao, X."Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point". Biomedical Reports 4, no. 2 (2016): 147-152. https://doi.org/10.3892/br.2015.555
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang B, Cheng M, Yang M, Han S, Zhang Y, Shi H, Zhu L and Zhao X: Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point. Biomed Rep 4: 147-152, 2016.
APA
Zhang, B., Cheng, M., Yang, M., Han, S., Zhang, Y., Shi, H. ... Zhao, X. (2016). Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point. Biomedical Reports, 4, 147-152. https://doi.org/10.3892/br.2015.555
MLA
Zhang, B., Cheng, M., Yang, M., Han, S., Zhang, Y., Shi, H., Zhu, L., Zhao, X."Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point". Biomedical Reports 4.2 (2016): 147-152.
Chicago
Zhang, B., Cheng, M., Yang, M., Han, S., Zhang, Y., Shi, H., Zhu, L., Zhao, X."Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point". Biomedical Reports 4, no. 2 (2016): 147-152. https://doi.org/10.3892/br.2015.555
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team